NASDAQ:GNCA
$0.0001
(
0%
)
Friday, 27th Jan 2023
Genocea Biosciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.0001 | $0.0064 | Friday, 27th Jan 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001. |
| 90 days | $0.0001 | $0.0150 | |
| 52 weeks | $0.0001 | $1.45 |
Historical Genocea Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 0 |
| 2023-01-26 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 0 |
| 2023-01-25 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 0 |
| 2023-01-24 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 0 |
| 2023-01-23 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 0 |
| 2023-01-20 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 9 316 |
| 2023-01-19 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 3 400 |
| 2023-01-18 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 2 718 |
| 2023-01-17 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 12 538 |
| 2023-01-13 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 61 824 |
| 2023-01-12 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 596 |
| 2023-01-11 | $0.0001 | $0.0064 | $0.0001 | $0.0001 | 15 239 |
| 2023-01-10 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 7 376 |
| 2023-01-09 | $0.0001 | $0.0064 | $0.0001 | $0.0001 | 186 133 |
| 2023-01-06 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 9 030 |
| 2023-01-05 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2023-01-04 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2023-01-03 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-30 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-29 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-28 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-27 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-23 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 0 |
| 2022-12-22 | $0.0007 | $0.0007 | $0.0006 | $0.0006 | 1 452 |
| 2022-12-21 | $0.0007 | $0.0007 | $0.0007 | $0.0007 | 102 733 |
| 2022-12-20 | $0.0007 | $0.0039 | $0.0007 | $0.0039 | 53 064 |
| 2022-12-19 | $0.0007 | $0.0029 | $0.0007 | $0.0029 | 61 938 |
| 2022-12-16 | $0.0006 | $0.0039 | $0.0006 | $0.0039 | 105 403 |
| 2022-12-15 | $0.0006 | $0.0039 | $0.0006 | $0.0039 | 51 400 |
| 2022-12-14 | $0.0006 | $0.0039 | $0.0006 | $0.0039 | 12 274 |
| 2022-12-13 | $0.0006 | $0.0039 | $0.0006 | $0.0039 | 11 252 |
| 2022-12-12 | $0.0011 | $0.0012 | $0.0006 | $0.0011 | 981 575 |
| 2022-12-09 | $0.0011 | $0.0020 | $0.0011 | $0.0020 | 3 163 |
| 2022-12-08 | $0.0020 | $0.0020 | $0.0020 | $0.0020 | 5 400 |
| 2022-12-07 | $0.0011 | $0.0011 | $0.0011 | $0.0011 | 0 |
| 2022-12-06 | $0.0011 | $0.0011 | $0.0011 | $0.0011 | 0 |
| 2022-12-05 | $0.0011 | $0.0011 | $0.0011 | $0.0011 | 0 |
| 2022-12-02 | $0.0011 | $0.0074 | $0.0011 | $0.0074 | 20 000 |
| 2022-12-01 | $0.0011 | $0.0074 | $0.0011 | $0.0074 | 73 801 |
| 2022-11-30 | $0.0011 | $0.0079 | $0.0011 | $0.0079 | 50 100 |
| 2022-11-29 | $0.0011 | $0.0079 | $0.0011 | $0.0079 | 20 355 |
| 2022-11-28 | $0.0011 | $0.0012 | $0.0011 | $0.0012 | 17 777 |
| 2022-11-25 | $0.0009 | $0.0100 | $0.0009 | $0.0011 | 26 105 |
| 2022-11-23 | $0.0009 | $0.0150 | $0.0009 | $0.0150 | 5 020 |
| 2022-11-22 | $0.0009 | $0.0100 | $0.0009 | $0.0100 | 8 504 |
| 2022-11-21 | $0.0007 | $0.0100 | $0.0007 | $0.0100 | 60 925 |
| 2022-11-18 | $0.0007 | $0.0100 | $0.0007 | $0.0100 | 213 129 |
| 2022-11-17 | $0.0007 | $0.0064 | $0.0007 | $0.0064 | 16 877 |
| 2022-11-16 | $0.0007 | $0.0007 | $0.0007 | $0.0007 | 11 889 |
| 2022-11-15 | $0.0007 | $0.0060 | $0.0007 | $0.0007 | 216 026 |
About Genocea Biosciences
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
